To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open35.46
High36.39
Low35
Prev. Close35.82
Avg. Traded Price35.16
Volume87,445

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
000
000
000
000
000
AskQtyOrders
000
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

35.002 hours ago
36.397 hours ago
arrow

LOWER/UPPER CIRCUITS

28.66
42.98
arrow
Vivo Bio Tech Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 13.16%, in the last year to ₹51.48 Cr. Its sector's average revenue growth for the last fiscal year was 10.77%.
noteAnnual Net Profit,rose 188.27% in the last year to ₹7.28 Cr. Its sector's average net profit growth for the last fiscal year was 38.71%.
notePrice to Earning Ratio,is 7.93, lower than its sector PE ratio of 43.54.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : -5%
Net profit growth 5Y CAGR : 2.34%
Vivo Bio Tech Ltd (VBTL) is a contract research company engaged in biotechnology and pharma drug discovery activities. VBTL provides services ranging from insilico design wet lab contract research preclinical research and clinical studies spanning the entire drug discovery value chain.The Custom Research Services group at Vivo Bio Tech offers a complete line of protein services including gene synthesis cloning expression and purification of recombinant proteins and monoclonal antibodies. In-vitro Services offers solutions for pharmacologic toxicological & bioanalytical investigations in drug discovery & development. Critical investigations like bacterial reverse mutation assays chromosomal aberration and micronucleus are some of the specialty services offered by the company.
personal

Grow your wealth with more research recommendations

+91